APO Research
Talk to an analyst

APO RESEARCH · REPORT

Orthobiologics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Orthobiologics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025198 pages

Choose your research edition.

Industry ResearchOrthobiologics Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal Orthobiologics Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Orthobiologics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Orthobiologics Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Orthobiologics Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Orthobiologics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Orthobiologics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Orthobiologics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Orthobiologics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Orthobiologics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Orthobiologics include Stryker Corporation, Sanofi-Aventis (Sanofi SA), Medtronic, Zimmer Biomet Holdings, TRB Chemedica International SA, Seikagaku Corporation, SeaSpine Holdings Corporation, RTI Surgical, Inc. and Orthofix International N.V., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Orthobiologics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Orthobiologics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Orthobiologics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Orthobiologics market size, projected growth trends, production technologies, key applications, and end-use industries.

Orthobiologics Segment by Company

Stryker Corporation

Sanofi-Aventis (Sanofi SA)

Medtronic

Zimmer Biomet Holdings

TRB Chemedica International SA

Seikagaku Corporation

SeaSpine Holdings Corporation

RTI Surgical, Inc.

Orthofix International N.V.

NuVasive, Inc.

Musculoskeletal Transplant Foundation, Inc.

Ito

Heraeus Holding GmbH

Fidia Pharma USA Inc.

Djo Global, Inc.

DePuy Synthes (Johnson & Johnson)

Bioventus

Arthrex, Inc.

Anika Therapeutics, Inc.

Allosource

Orthobiologics Segment by Type

Viscosupplements

Bone Graft Substitute

Bone Growth Stimulators (BGS)

Orthobiologics Segment by Application

Hospitals

Ambulatory Surgical Centres

Orthopaedics Clinics

Orthobiologics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orthobiologics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Orthobiologics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Orthobiologics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Orthobiologics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Orthobiologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Orthobiologics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Orthobiologics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Orthobiologics Industry Trends Table 2. Orthobiologics Industry Drivers Table 3. Orthobiologics Industry Opportunities and Challenges Table 4. Orthobiologics Industry Restraints Table 5. Global Orthobiologics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Orthobiologics Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Orthobiologics Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Orthobiologics Sales Market Share by Manufacturers Table 9. Global Orthobiologics Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Orthobiologics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Orthobiologics Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Orthobiologics Manufacturers, Product Type & Application Table 13. Global Orthobiologics Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Orthobiologics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Viscosupplements Table 17. Major Manufacturers of Bone Graft Substitute Table 18. Major Manufacturers of Bone Growth Stimulators (BGS) Table 19. Global Orthobiologics Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Orthobiologics Sales by Type (2021-2026) & (k units) Table 21. Global Orthobiologics Sales by Type (2027-2032) & (k units) Table 22. Global Orthobiologics Sales Market Share by Type (2021-2026) Table 23. Global Orthobiologics Sales Market Share by Type (2027-2032) Table 24. Global Orthobiologics Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Orthobiologics Revenue by Type (2021-2026) & (k units) Table 26. Global Orthobiologics Revenue by Type (2027-2032) & (k units) Table 27. Global Orthobiologics Revenue Market Share by Type (2021-2026) Table 28. Global Orthobiologics Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospitals Table 30. Major Manufacturers of Ambulatory Surgical Centres Table 31. Major Manufacturers of Orthopaedics Clinics Table 32. Global Orthobiologics Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Orthobiologics Sales by Application (2021-2026) & (k units) Table 34. Global Orthobiologics Sales by Application (2027-2032) & (k units) Table 35. Global Orthobiologics Sales Market Share by Application (2021-2026) Table 36. Global Orthobiologics Sales Market Share by Application (2027-2032) Table 37. Global Orthobiologics Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Orthobiologics Revenue by Application (2021-2026) & (k units) Table 39. Global Orthobiologics Revenue by Application (2027-2032) & (k units) Table 40. Global Orthobiologics Revenue Market Share by Application (2021-2026) Table 41. Global Orthobiologics Revenue Market Share by Application (2027-2032) Table 42. Global Orthobiologics Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Orthobiologics Sales by Region (2021-2026) & (k units) Table 44. Global Orthobiologics Sales Market Share by Region (2021-2026) Table 45. Global Orthobiologics Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Orthobiologics Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Orthobiologics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Orthobiologics Sales by Country (2021-2026) & (k units) Table 49. North America Orthobiologics Sales by Country (2027-2032) & (k units) Table 50. Europe Orthobiologics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Orthobiologics Sales by Country (2021-2026) & (k units) Table 52. Europe Orthobiologics Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Orthobiologics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Orthobiologics Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Orthobiologics Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Orthobiologics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Orthobiologics Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Orthobiologics Sales by Country (2027-2032) & (k units) Table 59. Global Orthobiologics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Orthobiologics Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Orthobiologics Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Orthobiologics Revenue Market Share by Region (2021-2026) Table 63. Global Orthobiologics Revenue Market Share by Region (2027-2032) Table 64. Stryker Corporation Company Information Table 65. Stryker Corporation Business Overview Table 66. Stryker Corporation Orthobiologics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Stryker Corporation Orthobiologics Product Portfolio Table 68. Stryker Corporation Recent Development Table 69. Sanofi-Aventis (Sanofi SA) Company Information Table 70. Sanofi-Aventis (Sanofi SA) Business Overview Table 71. Sanofi-Aventis (Sanofi SA) Orthobiologics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Sanofi-Aventis (Sanofi SA) Orthobiologics Product Portfolio Table 73. Sanofi-Aventis (Sanofi SA) Recent Development Table 74. Medtronic Company Information Table 75. Medtronic Business Overview Table 76. Medtronic Orthobiologics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Medtronic Orthobiologics Product Portfolio Table 78. Medtronic Recent Development Table 79. Zimmer Biomet Holdings Company Information Table 80. Zimmer Biomet Holdings Business Overview Table 81. Zimmer Biomet Holdings Orthobiologics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Zimmer Biomet Holdings Orthobiologics Product Portfolio Table 83. Zimmer Biomet Holdings Recent Development Table 84. TRB Chemedica International SA Company Information Table 85. TRB Chemedica International SA Business Overview Table 86. TRB Chemedica International SA Orthobiologics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. TRB Chemedica International SA Orthobiologics Product Portfolio Table 88. TRB Chemedica International SA Recent Development Table 89. Seikagaku Corporation Company Information Table 90. Seikagaku Corporation Business Overview Table 91. Seikagaku Corporation Orthobiologics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Seikagaku Corporation Orthobiologics Product Portfolio Table 93. Seikagaku Corporation Recent Development Table 94. SeaSpine Holdings Corporation Company Information Table 95. SeaSpine Holdings Corporation Business Overview Table 96. SeaSpine Holdings Corporation Orthobiologics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. SeaSpine Holdings Corporation Orthobiologics Product Portfolio Table 98. SeaSpine Holdings Corporation Recent Development Table 99. RTI Surgical, Inc. Company Information Table 100. RTI Surgical, Inc. Business Overview Table 101. RTI Surgical, Inc. Orthobiologics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. RTI Surgical, Inc. Orthobiologics Product Portfolio Table 103. RTI Surgical, Inc. Recent Development Table 104. Orthofix International N.V. Company Information Table 105. Orthofix International N.V. Business Overview Table 106. Orthofix International N.V. Orthobiologics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Orthofix International N.V. Orthobiologics Product Portfolio Table 108. Orthofix International N.V. Recent Development Table 109. NuVasive, Inc. Company Information Table 110. NuVasive, Inc. Business Overview Table 111. NuVasive, Inc. Orthobiologics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. NuVasive, Inc. Orthobiologics Product Portfolio Table 113. NuVasive, Inc. Recent Development Table 114. Musculoskeletal Transplant Foundation, Inc. Company Information Table 115. Musculoskeletal Transplant Foundation, Inc. Business Overview Table 116. Musculoskeletal Transplant Foundation, Inc. Orthobiologics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Musculoskeletal Transplant Foundation, Inc. Orthobiologics Product Portfolio Table 118. Musculoskeletal Transplant Foundation, Inc. Recent Development Table 119. Ito Company Information Table 120. Ito Business Overview Table 121. Ito Orthobiologics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Ito Orthobiologics Product Portfolio Table 123. Ito Recent Development Table 124. Heraeus Holding GmbH Company Information Table 125. Heraeus Holding GmbH Business Overview Table 126. Heraeus Holding GmbH Orthobiologics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Heraeus Holding GmbH Orthobiologics Product Portfolio Table 128. Heraeus Holding GmbH Recent Development Table 129. Fidia Pharma USA Inc. Company Information Table 130. Fidia Pharma USA Inc. Business Overview Table 131. Fidia Pharma USA Inc. Orthobiologics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Fidia Pharma USA Inc. Orthobiologics Product Portfolio Table 133. Fidia Pharma USA Inc. Recent Development Table 134. Djo Global, Inc. Company Information Table 135. Djo Global, Inc. Business Overview Table 136. Djo Global, Inc. Orthobiologics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Djo Global, Inc. Orthobiologics Product Portfolio Table 138. Djo Global, Inc. Recent Development Table 139. DePuy Synthes (Johnson & Johnson) Company Information Table 140. DePuy Synthes (Johnson & Johnson) Business Overview Table 141. DePuy Synthes (Johnson & Johnson) Orthobiologics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. DePuy Synthes (Johnson & Johnson) Orthobiologics Product Portfolio Table 143. DePuy Synthes (Johnson & Johnson) Recent Development Table 144. Bioventus Company Information Table 145. Bioventus Business Overview Table 146. Bioventus Orthobiologics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Bioventus Orthobiologics Product Portfolio Table 148. Bioventus Recent Development Table 149. Arthrex, Inc. Company Information Table 150. Arthrex, Inc. Business Overview Table 151. Arthrex, Inc. Orthobiologics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. Arthrex, Inc. Orthobiologics Product Portfolio Table 153. Arthrex, Inc. Recent Development Table 154. Anika Therapeutics, Inc. Company Information Table 155. Anika Therapeutics, Inc. Business Overview Table 156. Anika Therapeutics, Inc. Orthobiologics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. Anika Therapeutics, Inc. Orthobiologics Product Portfolio Table 158. Anika Therapeutics, Inc. Recent Development Table 159. Allosource Company Information Table 160. Allosource Business Overview Table 161. Allosource Orthobiologics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 162. Allosource Orthobiologics Product Portfolio Table 163. Allosource Recent Development Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Orthobiologics Distributors List Table 167. Orthobiologics Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Orthobiologics Product Image Figure 2. Global Orthobiologics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Orthobiologics Market Size (2021-2032) & (US$ Million) Figure 4. Global Orthobiologics Sales (2021-2032) & (k units) Figure 5. Global Orthobiologics Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Orthobiologics Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Viscosupplements Image Figure 9. Bone Graft Substitute Image Figure 10. Bone Growth Stimulators (BGS) Image Figure 11. Global Orthobiologics Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Orthobiologics Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Orthobiologics Sales Market Share by Type (2021-2032) Figure 14. Global Orthobiologics Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Orthobiologics Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Orthobiologics Revenue Market Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Ambulatory Surgical Centres Image Figure 19. Orthopaedics Clinics Image Figure 20. Global Orthobiologics Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Orthobiologics Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Orthobiologics Sales Market Share by Application (2021-2032) Figure 23. Global Orthobiologics Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Orthobiologics Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Orthobiologics Revenue Market Share by Application (2021-2032) Figure 26. North America Orthobiologics Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Orthobiologics Sales Market Share by Country (2021-2032) Figure 28. U.S. Orthobiologics Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Orthobiologics Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Orthobiologics Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Orthobiologics Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Orthobiologics Sales Market Share by Country (2021-2032) Figure 33. Germany Orthobiologics Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Orthobiologics Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Orthobiologics Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Orthobiologics Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Orthobiologics Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Orthobiologics Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Orthobiologics Sales Market Share by Country (2021-2032) Figure 40. China Orthobiologics Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Orthobiologics Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Orthobiologics Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Orthobiologics Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Orthobiologics Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Orthobiologics Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Orthobiologics Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Orthobiologics Sales Market Share by Country (2021-2032) Figure 48. Brazil Orthobiologics Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Orthobiologics Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Orthobiologics Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Orthobiologics Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Orthobiologics Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Orthobiologics Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Orthobiologics Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Orthobiologics Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Orthobiologics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Orthobiologics Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Orthobiologics Revenue (2021-2032) & (US$ Million) Figure 59. North America Orthobiologics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Orthobiologics Revenue (2021-2032) & (US$ Million) Figure 61. Europe Orthobiologics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Orthobiologics Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Orthobiologics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Orthobiologics Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Orthobiologics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Orthobiologics Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Orthobiologics Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Viscosupplements
  • Bone Graft Substitute
  • Bone Growth Stimulators (BGS)
Applications
  • Hospitals
  • Ambulatory Surgical Centres
  • Orthopaedics Clinics
Companies covered
  • Stryker Corporation
  • Sanofi-Aventis (Sanofi SA)
  • Medtronic
  • Zimmer Biomet Holdings
  • TRB Chemedica International SA
  • Seikagaku Corporation
  • SeaSpine Holdings Corporation
  • RTI Surgical, Inc.
  • Orthofix International N.V.
  • NuVasive, Inc.
  • Musculoskeletal Transplant Foundation, Inc.
  • Ito
  • Heraeus Holding GmbH
  • Fidia Pharma USA Inc.
  • Djo Global, Inc.
  • DePuy Synthes (Johnson & Johnson)
  • Bioventus
  • Arthrex, Inc.
  • Anika Therapeutics, Inc.
  • Allosource

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Orthobiologics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Orthobiologics Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Orthobiologics Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Orthobiologics Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Orthobiologics Market Dynamics
  1. 2.1 Orthobiologics Industry Trends
  2. 2.2 Orthobiologics Industry Drivers
  3. 2.3 Orthobiologics Industry Opportunities and Challenges
  4. 2.4 Orthobiologics Industry Restraints
3 Orthobiologics Market by Manufacturers
  1. 3.1 Global Orthobiologics Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Orthobiologics Sales by Manufacturers (2021-2026)
  3. 3.3 Global Orthobiologics Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Orthobiologics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Orthobiologics Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Orthobiologics Manufacturers, Product Type & Application
  7. 3.7 Global Orthobiologics Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Orthobiologics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Orthobiologics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Orthobiologics Tier 1, Tier 2, and Tier 3
4 Orthobiologics Market by Type
  1. 4.1 Orthobiologics Type Introduction
  2. 4.1.1 Viscosupplements
  3. 4.1.2 Bone Graft Substitute
  4. 4.1.3 Bone Growth Stimulators (BGS)
  5. 4.2 Global Orthobiologics Sales by Type
  6. 4.2.1 Global Orthobiologics Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Orthobiologics Sales by Type (2021-2032)
  8. 4.2.3 Global Orthobiologics Sales Market Share by Type (2021-2032)
  9. 4.3 Global Orthobiologics Revenue by Type
  10. 4.3.1 Global Orthobiologics Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Orthobiologics Revenue by Type (2021-2032)
  12. 4.3.3 Global Orthobiologics Revenue Market Share by Type (2021-2032)
5 Orthobiologics Market by Application
  1. 5.1 Orthobiologics Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Ambulatory Surgical Centres
  4. 5.1.3 Orthopaedics Clinics
  5. 5.2 Global Orthobiologics Sales by Application
  6. 5.2.1 Global Orthobiologics Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Orthobiologics Sales by Application (2021-2032)
  8. 5.2.3 Global Orthobiologics Sales Market Share by Application (2021-2032)
  9. 5.3 Global Orthobiologics Revenue by Application
  10. 5.3.1 Global Orthobiologics Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Orthobiologics Revenue by Application (2021-2032)
  12. 5.3.3 Global Orthobiologics Revenue Market Share by Application (2021-2032)
6 Global Orthobiologics Sales by Region
  1. 6.1 Global Orthobiologics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Orthobiologics Sales by Region (2021-2032)
  3. 6.2.1 Global Orthobiologics Sales by Region (2021-2026)
  4. 6.2.2 Global Orthobiologics Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Orthobiologics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Orthobiologics Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Orthobiologics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Orthobiologics Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Orthobiologics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Orthobiologics Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Orthobiologics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Orthobiologics Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Orthobiologics Revenue by Region
  1. 7.1 Global Orthobiologics Revenue by Region
  2. 7.1.1 Global Orthobiologics Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Orthobiologics Revenue by Region (2021-2026)
  4. 7.1.3 Global Orthobiologics Revenue by Region (2027-2032)
  5. 7.1.4 Global Orthobiologics Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Orthobiologics Revenue (2021-2032)
  8. 7.2.2 North America Orthobiologics Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Orthobiologics Revenue (2021-2032)
  11. 7.3.2 Europe Orthobiologics Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Orthobiologics Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Orthobiologics Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Orthobiologics Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Orthobiologics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Stryker Corporation
  2. 8.1.1 Stryker Corporation Company Information
  3. 8.1.2 Stryker Corporation Business Overview
  4. 8.1.3 Stryker Corporation Orthobiologics Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Stryker Corporation Orthobiologics Product Portfolio
  6. 8.1.5 Stryker Corporation Recent Developments
  7. 8.2 Sanofi-Aventis (Sanofi SA)
  8. 8.2.1 Sanofi-Aventis (Sanofi SA) Company Information
  9. 8.2.2 Sanofi-Aventis (Sanofi SA) Business Overview
  10. 8.2.3 Sanofi-Aventis (Sanofi SA) Orthobiologics Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi-Aventis (Sanofi SA) Orthobiologics Product Portfolio
  12. 8.2.5 Sanofi-Aventis (Sanofi SA) Recent Developments
  13. 8.3 Medtronic
  14. 8.3.1 Medtronic Company Information
  15. 8.3.2 Medtronic Business Overview
  16. 8.3.3 Medtronic Orthobiologics Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Medtronic Orthobiologics Product Portfolio
  18. 8.3.5 Medtronic Recent Developments
  19. 8.4 Zimmer Biomet Holdings
  20. 8.4.1 Zimmer Biomet Holdings Company Information
  21. 8.4.2 Zimmer Biomet Holdings Business Overview
  22. 8.4.3 Zimmer Biomet Holdings Orthobiologics Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Zimmer Biomet Holdings Orthobiologics Product Portfolio
  24. 8.4.5 Zimmer Biomet Holdings Recent Developments
  25. 8.5 TRB Chemedica International SA
  26. 8.5.1 TRB Chemedica International SA Company Information
  27. 8.5.2 TRB Chemedica International SA Business Overview
  28. 8.5.3 TRB Chemedica International SA Orthobiologics Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 TRB Chemedica International SA Orthobiologics Product Portfolio
  30. 8.5.5 TRB Chemedica International SA Recent Developments
  31. 8.6 Seikagaku Corporation
  32. 8.6.1 Seikagaku Corporation Company Information
  33. 8.6.2 Seikagaku Corporation Business Overview
  34. 8.6.3 Seikagaku Corporation Orthobiologics Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Seikagaku Corporation Orthobiologics Product Portfolio
  36. 8.6.5 Seikagaku Corporation Recent Developments
  37. 8.7 SeaSpine Holdings Corporation
  38. 8.7.1 SeaSpine Holdings Corporation Company Information
  39. 8.7.2 SeaSpine Holdings Corporation Business Overview
  40. 8.7.3 SeaSpine Holdings Corporation Orthobiologics Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 SeaSpine Holdings Corporation Orthobiologics Product Portfolio
  42. 8.7.5 SeaSpine Holdings Corporation Recent Developments
  43. 8.8 RTI Surgical, Inc.
  44. 8.8.1 RTI Surgical, Inc. Company Information
  45. 8.8.2 RTI Surgical, Inc. Business Overview
  46. 8.8.3 RTI Surgical, Inc. Orthobiologics Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 RTI Surgical, Inc. Orthobiologics Product Portfolio
  48. 8.8.5 RTI Surgical, Inc. Recent Developments
  49. 8.9 Orthofix International N.V.
  50. 8.9.1 Orthofix International N.V. Company Information
  51. 8.9.2 Orthofix International N.V. Business Overview
  52. 8.9.3 Orthofix International N.V. Orthobiologics Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Orthofix International N.V. Orthobiologics Product Portfolio
  54. 8.9.5 Orthofix International N.V. Recent Developments
  55. 8.10 NuVasive, Inc.
  56. 8.10.1 NuVasive, Inc. Company Information
  57. 8.10.2 NuVasive, Inc. Business Overview
  58. 8.10.3 NuVasive, Inc. Orthobiologics Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 NuVasive, Inc. Orthobiologics Product Portfolio
  60. 8.10.5 NuVasive, Inc. Recent Developments
  61. 8.11 Musculoskeletal Transplant Foundation, Inc.
  62. 8.11.1 Musculoskeletal Transplant Foundation, Inc. Company Information
  63. 8.11.2 Musculoskeletal Transplant Foundation, Inc. Business Overview
  64. 8.11.3 Musculoskeletal Transplant Foundation, Inc. Orthobiologics Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Musculoskeletal Transplant Foundation, Inc. Orthobiologics Product Portfolio
  66. 8.11.5 Musculoskeletal Transplant Foundation, Inc. Recent Developments
  67. 8.12 Ito
  68. 8.12.1 Ito Company Information
  69. 8.12.2 Ito Business Overview
  70. 8.12.3 Ito Orthobiologics Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Ito Orthobiologics Product Portfolio
  72. 8.12.5 Ito Recent Developments
  73. 8.13 Heraeus Holding GmbH
  74. 8.13.1 Heraeus Holding GmbH Company Information
  75. 8.13.2 Heraeus Holding GmbH Business Overview
  76. 8.13.3 Heraeus Holding GmbH Orthobiologics Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Heraeus Holding GmbH Orthobiologics Product Portfolio
  78. 8.13.5 Heraeus Holding GmbH Recent Developments
  79. 8.14 Fidia Pharma USA Inc.
  80. 8.14.1 Fidia Pharma USA Inc. Company Information
  81. 8.14.2 Fidia Pharma USA Inc. Business Overview
  82. 8.14.3 Fidia Pharma USA Inc. Orthobiologics Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Fidia Pharma USA Inc. Orthobiologics Product Portfolio
  84. 8.14.5 Fidia Pharma USA Inc. Recent Developments
  85. 8.15 Djo Global, Inc.
  86. 8.15.1 Djo Global, Inc. Company Information
  87. 8.15.2 Djo Global, Inc. Business Overview
  88. 8.15.3 Djo Global, Inc. Orthobiologics Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Djo Global, Inc. Orthobiologics Product Portfolio
  90. 8.15.5 Djo Global, Inc. Recent Developments
  91. 8.16 DePuy Synthes (Johnson & Johnson)
  92. 8.16.1 DePuy Synthes (Johnson & Johnson) Company Information
  93. 8.16.2 DePuy Synthes (Johnson & Johnson) Business Overview
  94. 8.16.3 DePuy Synthes (Johnson & Johnson) Orthobiologics Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 DePuy Synthes (Johnson & Johnson) Orthobiologics Product Portfolio
  96. 8.16.5 DePuy Synthes (Johnson & Johnson) Recent Developments
  97. 8.17 Bioventus
  98. 8.17.1 Bioventus Company Information
  99. 8.17.2 Bioventus Business Overview
  100. 8.17.3 Bioventus Orthobiologics Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Bioventus Orthobiologics Product Portfolio
  102. 8.17.5 Bioventus Recent Developments
  103. 8.18 Arthrex, Inc.
  104. 8.18.1 Arthrex, Inc. Company Information
  105. 8.18.2 Arthrex, Inc. Business Overview
  106. 8.18.3 Arthrex, Inc. Orthobiologics Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Arthrex, Inc. Orthobiologics Product Portfolio
  108. 8.18.5 Arthrex, Inc. Recent Developments
  109. 8.19 Anika Therapeutics, Inc.
  110. 8.19.1 Anika Therapeutics, Inc. Company Information
  111. 8.19.2 Anika Therapeutics, Inc. Business Overview
  112. 8.19.3 Anika Therapeutics, Inc. Orthobiologics Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Anika Therapeutics, Inc. Orthobiologics Product Portfolio
  114. 8.19.5 Anika Therapeutics, Inc. Recent Developments
  115. 8.20 Allosource
  116. 8.20.1 Allosource Company Information
  117. 8.20.2 Allosource Business Overview
  118. 8.20.3 Allosource Orthobiologics Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Allosource Orthobiologics Product Portfolio
  120. 8.20.5 Allosource Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Orthobiologics Value Chain Analysis
  2. 9.1.1 Orthobiologics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Orthobiologics Production Mode & Process
  6. 9.2 Orthobiologics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Orthobiologics Distributors
  9. 9.2.3 Orthobiologics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst